Clearing Up Misperceptions About the Pain Standards

Published Online: Friday, November 1, 2013
Follow Pharmacy_Times:
In this podcast, Pat Adamski, director of the Joint Commission's Standards Interpretations Group, clears up common misperceptions about the organization's pain standards.

To listen to the podcast, click here.
Related Articles
Drugs that contain hydrocodone will be moved to a more restrictive category of the Controlled Substances Act.
Aspirin not only prevents the production of pain-causing compounds in the body, but also triggers an enzyme to speed the reduction of inflammation.
Galleon Pharmaceuticals Corp's GAL-021 reverses and prevents respiratory depression associated with opioid use without affecting analgesia.
The Drug Enforcement Administration has officially placed tramadol, a centrally acting opioid analgesic, into schedule IV of the Controlled Substances Act.
Latest Issues
$auto_registration$